CROSS RESISTANCE PROFILES OF HUMAN OVARIAN-CARCINOMA CELLS SELECTED FOR RESISTANCE TO N-PHOSPHONACETYL-L-ASPARTATE (PALA)

被引：0
|
作者：
CHAN, TCK [1 ]
机构：
[1] PURDUE UNIV,SCH VET MED,DEPT PHYSIOL & PHARMACOL,W LAFAYETTE,IN 47907
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1988年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：299 / 299
页数：1
相关论文
共 50 条
  • [41] Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate (PALA) is inactive in advanced pancreatic carcinoma
    Harstrick, A
    Kohne, CH
    Hiddemann, W
    Preusser, P
    Strumberg, D
    Berns, T
    Seeber, S
    Wilke, H
    Schmoll, HJ
    ANNALS OF ONCOLOGY, 1997, 8 (09) : 917 - 918
  • [42] MODULATION OF THE ANTITUMOR-ACTIVITY OF 5-FLUOROURACIL AND CISPLATINUM BY N-PHOSPHONACETYL-L-ASPARTATE IN THE MURINE COLON-CARCINOMA NUMBER-26
    DURRANI, FA
    CAO, SS
    VANLAAR, JAM
    RUSTUM, YM
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 5 (05) : 1065 - 1068
  • [43] PERIPHERAL LEUKOCYTES AS INDICATORS OF THE ENZYMATIC EFFECTS OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA) ON HUMAN L-ASPARTATE TRANSCARBAMOYLASE (ATCASE) ACTIVITY
    KENSLER, TW
    ERLICHMAN, C
    JAYARAM, HN
    TYAGI, AK
    ARDALAN, B
    COONEY, DA
    CANCER TREATMENT REPORTS, 1980, 64 (8-9): : 967 - 973
  • [44] DNA CROSS-LINKING AND PLATINUM RESISTANCE IN OVARIAN-CARCINOMA CELL-LINES
    BEATTIE, GJ
    HAYWARD, IP
    SMYTH, JF
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 202 - 202
  • [45] THERAPEUTIC SYNERGISM (TS) WITH L-ALANOSINE (A) PLUS N-PHOSPHONACETYL-L-ASPARTATE (PALA) AGAINST ARA-C-RESISTANT LEUKEMIA P388 (P388/ARA-C)
    TRADER, MW
    SCHABEL, FM
    LASTER, WR
    BROCKMAN, RW
    KOVACH, JS
    LIEBER, MM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 187 - 187
  • [46] HUMAN-BREAST CANCER-CELLS RESISTANT TO PALA (N-PHOSPHONOACETYL-L-ASPARTATE)
    COWAN, K
    LIPPMAN, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 41 - 41
  • [47] INDUCTION OF IMMUNOCELLULAR RESISTANCE TO IL-2-ACTIVATED LYMPHOCYTES WITHIN OVARIAN-CARCINOMA CELLS
    PAPADOPOULOS, AJ
    HAN, X
    MATOSSIANROGERS, A
    RAJU, KS
    GYNECOLOGIC ONCOLOGY, 1995, 57 (03) : 388 - 394
  • [48] REVERSAL OF CISPLATINUM (CDDP) RESISTANCE BY CYCLOSPORIN-A (CSA) IN XENOGRAFTS OF FRESH HUMAN OVARIAN-CARCINOMA
    STRATTON, JA
    DISAIA, PJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 479 - 479
  • [49] MODULATION OF THE ANTITUMOR-ACTIVITY OF CISPLATIN ALONE AND IN COMBINATION WITH 5-FLUORO-2'-DEOXYURIDINE BY N-PHOSPHONACETYL-L-ASPARTATE IN MURINE COLON-CARCINOMA NO-26
    VANLAAR, JAM
    MAYHEW, EG
    CAO, S
    DURRANI, FA
    PETERS, GJ
    RUSTUM, YM
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (06) : 974 - 976
  • [50] MECHANISM OF RESISTANCE OF VARIANTS OF THE LEWIS LUNG-CARCINOMA TO N-(PHOSPHONACETYL)-L-ASPARTIC ACID
    KENSLER, TW
    MUTTER, G
    HANKERSON, JG
    RECK, LJ
    HARLEY, C
    HAN, N
    ARDALAN, B
    CYSYK, RL
    JOHNSON, RK
    JAYARAM, HN
    COONEY, DA
    CANCER RESEARCH, 1981, 41 (03) : 894 - 904
12345